Acute lymphoblastic leukemia (ALL) is a type of blood and marrow cancer. It accounts for 80 percent of leukemia cases in children. About 25 percent of patients are older than age 40 at diagnosis; this leukemia represents about 20 percent of all adult leukemia cases.
Some risk factors for developing acute lymphoblastic leukemia include prior exposure to chemotherapy or radiation therapy, and the presence of rare genetic conditions, such as Down syndrome, Bloom syndrome and ataxia telangiectasia.
Why choose the UT Health San Antonio Cancer Center for acute lymphoblastic leukemia?
At the UT Health Cancer Center a multidisciplinary team led by hematologists who specialize in blood cancers, care for acute lymphoblastic leukemia patients in specialized clinics and hospital-based units. After rapid comprehensive evaluations and consultation with our team that includes pathologists specializing in blood, marrow and lymph node cancers, also called hematopathologists, at regularly conducted conferences, we’ll talk through the care plan devised for you or your child.
The cancer center’s pediatric and adult hematologists often work together to plan the diagnosis, chemotherapy and survivorship care of all patients with acute lymphoblastic leukemia. Clinical trial-based treatments are available. Tour hematology team partners with national organizations, including the Children’s Oncology Group and other National Cancer Institute groups.
Because the UT Health Cancer Center is designated by the National Cancer Institute (NCI), we are able to offer care delivered by teams specializing in all phases of clinical trials. Our clinical trials in acute lymphoblastic leukemia are often available for patients who are newly diagnosed. We also have clinical trials available to patients who have already completed other forms of treatment.
Make an appointment
To request an appointment with our team or to make a referral to one of our physicians, please call the main number: 210-450-1000 or 800-340-2872 or email CTRCReferral@uthscsa.edu.